InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Gerberding Julie L., 董事. Director active across 3 companies, notably CERNER Corp. Aggregated, 6 reports have been recorded. Activity tracked since 19 May 2021. The latest transaction was filed on 23 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Gerberding Julie L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
59,224 股Common StockSEC:0001193125-25-206249:0
17,199 股0Common StockSEC:0000950170-25-089961:0
15,032 股@ US$95.00100.0% 占其流量Common StockSEC:0001209191-22-035497:0
9,550 股@ US$73.510.0002% mcap100.0% 占其流量Common StockSEC:0001127602-22-007008:0
35,287 股0Common StockSEC:0001127602-21-028263:0
3,188 股0Common StockSEC:0001209191-21-034517:0
6 条申报中的 6 条
About Gerberding Julie L.
Julie L. Gerberding is a Board Member and Executive Vice President, Chief Patient Officer at CERNER Corp and Merck & Co., Inc. She plays a key role in the governance of these companies, bringing her expertise in health and management. Her involvement in the boards allows her to contribute to strategic decision-making and guide the companies toward a sustainable future.
